ESSA Pharma Inc.

EPIX

ESSA Pharma Inc.

EPIX

Insider Sentiment (TTM):

Last Purchase:2023-12-14Last Sale:2025-08-05Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2025-09-30Institutional Shares Owned:22,423,834Shares Outstanding:44,388,550Institutional Ownership Pct.:50.52%

Earnings Market Reaction:

Filing Date:N/APrice on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Assets
Cash And Cash Equivalents At Carrying Value	86	86	93	104	86	92	35	34	38	44	51	57
Short Term Investments	24	28	27	23	45	44	107	114	114	113	112	110
Assets Current
Assets Current	111	115	122	128	132	137	144	149	153	158	165	169
Receivables Net Current	1	0	0	0	0	0	0	0	0	0	0	0
Prepaid Expense Current	0	1	1	1	1	1	2	1	1	1	2	2
Deposits Assets Noncurrent	-	-	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Assets	111	115	123	128	133	138	144	149	154	159	165	170
Liabilities And Stockhold…
Accounts Payable And Accrued Liabilities Current	2	2	4	3	3	4	3	3	3	2	3	2
Liabilities Current
Liabilities Current	2	2	4	3	4	4	4	3	3	2	3	2
Operating Lease Liability Current	-	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Liability Noncurrent	-	0	0	0	0	0	0	0	0	0	0	0
Liabilities	2	2	4	4	4	4	4	3	3	2	3	2
Derivative Liabilities Noncurrent	-	-	-	-	-	-	-	-	-	-	-	0
Common Stock Value	280	280	280	280	280	280	279	278	278	278	278	278
Additional Paid In Capital	58	59	58	55	53	50	50	49	48	47	46	44
Stockholders Equity
Stockholders Equity	109	114	119	125	129	133	141	146	150	156	162	167
Accumulated Other Comprehensive Income Loss Net Of…	-2	-2	-2	-2	-2	-2	-2	-2	-2	-2	-2	-2
Retained Earnings Accumulated Deficit	-227	-223	-217	-208	-202	-194	-185	-179	-174	-167	-160	-153
Liabilities And Stockholders Equity	111	115	123	128	133	138	144	149	154	159	165	170
Common Stock Shares Issued	44	44	44	44	44	44	44	44	44	44	44	44
Shares Outstanding	44	44	44	44	44	44	44	44	44	44	44	44

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

No price variance data available.

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Liquidity Ratios
Current Ratio	69.07	67.17	33.12	38.64	36.95	32.89	40.75	42.57	44.98	73.66	56.07	73.17
Quick Ratio	68.84	66.65	32.74	38.45	36.61	32.61	40.30	42.41	44.78	73.16	55.56	72.39
Working Capital	108.90M	113.45M	118.42M	124.26M	128.52M	133.12M	140.34M	145.30M	149.88M	155.97M	161.65M	166.75M
Leverage & Debt
Debt to Equity	0.01	0.02	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.01	0.02	0.01
Debt Ratio	0.01	0.02	0.03	0.03	0.03	0.03	0.03	0.02	0.02	0.01	0.02	0.01
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Receivables Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.57	-0.64	-	-0.64	-0.62	-0.63	-0.58	-0.60	-0.62	-0.66	-0.74	-0.80
Free Cash Flow Per Share TTM	-0.47	-0.51	-0.50	-0.51	-0.54	-0.52	-0.50	-0.45	-0.52	-0.55	-0.60	-0.64
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-8.69%	2.75%	20.56%	7.38%	0.89%	-4.21%	-21.20%	-24.27%	-26.55%	-22.30%	-16.83%	-4.62%
EPS Growth (1Y)	-8.73%	2.40%	19.86%	6.92%	0.27%	-4.52%	-21.30%	-24.36%	-26.61%	-22.41%	-16.99%	-16.66%
Calculated Values
Free Cash Flow TTM	-20.88M	-22.43M	-22.40M	-22.72M	-23.84M	-23.00M	-22.19M	-19.78M	-22.77M	-24.18M	-26.56M	-28.00M
Net Debt	-85.95M	-86.31M	-93.31M	-103.71M	-85.99M	-91.68M	-35.34M	-33.70M	-38.47M	-44.30M	-51.22M	-57.08M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-08-05Sale

Owner: Bvf, Inc/Il, Lampert Mark…

Title: -

Shares: 156

Price/Share: $1.88

Value: $293.28

Shares Owned: 560,797

Relationship: TenPercentOwner

Ownership: Direct

2024-11-01Sale

Owner: Bb, Biotech Ag, Biotech G…

Title: -

Shares: 7,879,583

Price/Share: $1.52

Value: $11,976,966.16

Shares Owned: -

Relationship: TenPercentOwner

Ownership: Direct

2024-10-07Sale

Owner: Virsik, Peter

Title: Chief Operating Officer

Shares: 694

Price/Share: $6.03

Value: $4,184.82

Shares Owned: 7,776

Relationship: Officer

Ownership: Direct

2024-09-09Sale

Owner: Virsik, Peter

Title: Chief Operating Officer

Shares: 694

Price/Share: $6.00

Value: $4,164.00

Shares Owned: 8,470

Relationship: Officer

Ownership: Direct

2024-09-03Sale

Owner: Virsik, Peter

Title: Chief Operating Officer

Shares: 2,082

Price/Share: $6.03

Value: $12,554.46

Shares Owned: 9,164

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-08-05	Bvf, Inc/Il, Lampert Mark…	TenPercentOwner	-	Direct	Sale	156	1.88	$293.28	560,797	4
2024-11-01	Bb, Biotech Ag, Biotech G…	TenPercentOwner	-	Direct	Sale	7,879,583	1.52	$11,976,966.16	0	4
2024-10-07	Virsik, Peter	Officer	Chief Operating Officer	Direct	Sale	694	6.03	$4,184.82	7,776	4
2024-09-09	Virsik, Peter	Officer	Chief Operating Officer	Direct	Sale	694	6.00	$4,164.00	8,470	4
2024-09-03	Virsik, Peter	Officer	Chief Operating Officer	Direct	Sale	2,082	6.03	$12,554.46	9,164	4
2024-05-06	Virsik, Peter	Officer	Chief Operating Officer	Direct	Sale	694	6.95	$4,823.30	11,246	4
2024-04-05	Virsik, Peter	Officer	Chief Operating Officer	Direct	Sale	694	7.94	$5,510.36	11,940	4
2024-03-05	Virsik, Peter	Officer	Chief Operating Officer	Direct	Sale	694	8.98	$6,232.12	12,634	4
2024-02-06	Virsik, Peter	Officer	Chief Operating Officer	Direct	Sale	72,782	10.29	$748,926.78	13,328	4
2024-02-05	Virsik, Peter	Officer	Chief Operating Officer	Direct	Sale	1,194	9.64	$11,510.16	13,328	4
2024-01-16	Virsik, Peter	Officer	Chief Operating Officer	Direct	Sale	1,718	10.01	$17,197.18	14,022	4
2024-01-05	Virsik, Peter	Officer	Chief Operating Officer	Direct	Sale	699	6.11	$4,270.89	14,022	4
2023-12-14	Parkinson, David Ross	Director,Officer	Chief Executive Officer	Direct	Purchase	9,223	2.30	$21,212.90	65,675	4
2023-11-21	Berger, Franklin M	Director	-	Direct	Purchase	23,259	5.73	$133,274.07	784,404	4
2023-11-03	Berger, Franklin M	Director	-	Direct	Purchase	16,471	5.99	$98,661.29	760,875	4
2022-12-30	Parkinson, David Ross	Director,Officer	Chief Executive Officer	Direct	Purchase	3,067	2.60	$7,974.20	56,542	4
2022-12-30	Wood, David S.	Officer	Chief Financial Officer	Direct	Purchase	8,302	2.60	$21,585.20	33,343	4
2022-12-21	Berger, Franklin M	Director	-	Direct	Sale	72,223	2.42	$174,779.66	684,404	4
2022-10-27	Biotech, Growth N V, Bb B…	TenPercentOwner	-	Direct	Purchase	500,000	4.50	$2,250,000.00	7,879,583	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-09-30

50.52%

Inst. Shares: 22,423,834

Shares Outstanding: 44,388,550

2025-06-30

69.77%

Inst. Shares: 30,971,803

Shares Outstanding: 44,388,550

2025-03-31

71.37%

Inst. Shares: 31,681,356

Shares Outstanding: 44,388,550

2024-12-31

73.94%

Inst. Shares: 32,818,772

Shares Outstanding: 44,388,550

2024-09-30

79.10%

Inst. Shares: 35,024,027

Shares Outstanding: 44,277,050

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-09-30	22,423,834	44,388,550	50.52%
2025-06-30	30,971,803	44,388,550	69.77%
2025-03-31	31,681,356	44,388,550	71.37%
2024-12-31	32,818,772	44,388,550	73.94%
2024-09-30	35,024,027	44,277,050	79.10%
2024-06-30	35,128,213	44,365,505	79.18%
2024-03-31	34,935,859	44,237,124	78.97%
2023-12-31	34,631,392	44,129,491	78.48%
2023-09-30	33,092,221	44,089,557	75.06%
2023-06-30	32,943,726	44,092,374	74.72%
2023-03-31	32,298,508	44,092,374	73.25%
2022-12-31	32,287,626	44,073,286	73.26%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

ESSA Pharma Inc. (EPIX) — SEC Financial Statements & Analysis

ESSA Pharma Inc. (EPIX) is a pharmaceutical preparations company, incorporated in A1. ESSA Pharma Inc. trades on None as: EPIX. Based on its latest SEC filing (Form 10-Q, period ending 2025-06-30), ESSA Pharma Inc. reported a Debt-to-Equity ratio of 0.01x. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.01x

Data as of 2025-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ESSA Pharma Inc. in?

ESSA Pharma Inc. (EPIX) operates in the Pharmaceutical Preparations industry.

What exchange does EPIX trade on?

ESSA Pharma Inc. (EPIX) trades on the None.

Where is ESSA Pharma Inc. incorporated?

ESSA Pharma Inc. is incorporated in British Columbia, Canada.

ESSA Pharma Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

ESSA Pharma Inc. (EPIX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

ESSA Pharma Inc. (EPIX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.